August 8, 2018

Insys to pay $150M to settle DOJ Subsys probe

Insys Therapeutics may soon turn the page on the high-profile federal probe into its Subsys sales practices—a probe that has already snared a half-dozen former Insys managers now facing criminal charges.

The company said Wednesday it agreed to pay the Justice Department $150 million to wrap up its role in the off-label marketing scheme. 

Read the source article at Pharma News

Additional Articles You May Like

Sign Up To Receive Our Free Newsletter